Development of a Nanostructured Platform for Identifying HER2-Heterogeneity of Breast Cancer Cells by Surface-Enhanced Raman Scattering

Biosensor technology has great potential for the detection of cancer through tumor-associated molecular biomarkers. In this work, we describe the immobilization of the recombinant humanized anti-HER2 monoclonal antibody (trastuzumab) on a silver nanostructured plate made by pulsed laser deposition (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nanomaterials (Basel)
Main Authors: Téllez-Plancarte, Alexandro, Haro-Poniatowski, Emmanuel, Picquart, Michel, Morales-Méndez, José Guadalupe, Lara-Cruz, Carlos, Jiménez-Salazar, Javier Esteban, Damián-Matsumura, Pablo, Escobar-Alarcón, Luis, Batina, Nikola
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071071/
https://ncbi.nlm.nih.gov/pubmed/30036967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nano8070549
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares